Text Size

CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier:
NCT01773980
First received: January 18, 2013
Last updated: March 8, 2013
Last verified: March 2013
History of Changes
  Purpose

The goal of this project is to develop and pilot test an innovative approach for overcoming barriers to cancer screening among women with physical disabilities (WWD) in rural Oregon. Many studies have shown that people with disabilities receive fewer indicated cancer screening services and are more likely to have poor cancer-related outcomes, such as late stage at diagnosis, compared to those without disabilities.


Condition Intervention
Breast Cancer
Cervical Cancer
Colorectal Cancer
 Other: Clinic Intervention
Other: Patient Intervention

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by OHSU Knight Cancer Institute:

Primary Outcome Measures:
  • Number of participants with improved cancer screening [ Time Frame: Duration of the study; Up to 1 year ] [ Designated as safety issue: No ]
    A 2 x 2 factorial study design will be used to explore individual and combined effects of a clinic-based intervention AND a patient-based intervention on improving breast, cervical and colorectal cancer screening among rural women with physical disabilities (WWD).


Estimated Enrollment: 400
Study Start Date: January 2013
Estimated Study Completion Date: August 2014
Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patient and Clinic Intervention

The patient intervention consists of a single 90-minute interactive in-person session.

The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.

 Other: Clinic Intervention
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Other: Patient Intervention
The patient intervention consists of a single 90-minute interactive in-person session.
Patient Intervention Only
The patient intervention consists of a single 90-minute interactive in-person session.
 Other: Patient Intervention
The patient intervention consists of a single 90-minute interactive in-person session.
Clinic Intervention Only
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
 Other: Clinic Intervention
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Neither Clinic nor Patient Intervention
Consists of no intervention

  Eligibility

Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Primary care clinics

Criteria

Inclusion Criteria:

  • Female
  • Aged 50-75 at time of screening
  • No personal history of breast, cervical or colorectal cancer
  • Not being up-to-date with at least one screening test for breast, cervical, and/or colorectal cancer
  • Meets the study definition of disability per APCC-1 (intervention group) OR
  • Be a woman who does not meet the definition of disability on APCC-1, but has been matched to a participant who does (observation group).

Exclusion Criteria:

  • Non female
  • Personal history of breast, cervical, or colorectal cancer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01773980

Locations
United States, Oregon
OHSU Knight Cancer Institute
Portland, Oregon, United States, 97239
Sponsors and Collaborators
OHSU Knight Cancer Institute
National Institutes of Health (NIH)
Investigators
Principal Investigator: David Buckley, MD Oregon Health and Science University
  More Information

No publications provided

Responsible Party: OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier: NCT01773980     History of Changes
Other Study ID Numbers: IRB00009030
Study First Received: January 18, 2013
Last Updated: March 8, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Uterine Cervical Neoplasms
Colorectal Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Uterine Cervical Diseases
 Uterine Diseases
Genital Diseases, Female
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on June 13, 2013